Table I.
Cell Line | Histology | Relative IC50 (μM) | R2 | Panel rIC50/ Line rIC50 | Ymin (%) |
---|---|---|---|---|---|
RD | Rhabdomyosarcoma | 0.9 | 0.95 | 0.95 | 0.1 |
Rh41 | Rhabdomyosarcoma | 0.5 | 0.99 | 1.66 | 0.0 |
Rh18 | Rhabdomyosarcoma | 1.6 | 0.97 | 0.56 | 2.0 |
Rh30 | Rhabdomyosarcoma | 0.8 | 0.97 | 1.08 | 0.3 |
BT-12 | Rhabdoid | 0.8 | 0.99 | 1.09 | 0.1 |
CHLA-266 | Rhabdoid | 0.4 | 0.91 | 2.06 | 0.2 |
TC-71 | Ewing sarcoma | 0.6 | 0.99 | 1.40 | 0.0 |
CHLA-9 | Ewing sarcoma | 1.2 | 0.98 | 0.73 | 0.1 |
CHLA-10 | Ewing sarcoma | 1.0 | 0.98 | 0.90 | 0.1 |
CHLA-258 | Ewing sarcoma | 0.5 | 0.88 | 1.77 | 0.0 |
SJ-GBM2 | Glioblastoma | 0.9 | 0.95 | 0.96 | 1.6 |
NB-1643 | Neuroblastoma | 1.9 | 0.95 | 0.47 | 1.1 |
NB-EBc1 | Neuroblastoma | 1.5 | 0.99 | 0.57 | 1.1 |
CHLA-90 | Neuroblastoma | 3.7 | 0.97 | 0.24 | 3.5 |
CHLA-136 | Neuroblastoma | 4.7 | 0.92 | 0.18 | 3.3 |
NALM-6 | ALL | 0.9 | 0.98 | 1.00 | 0.0 |
COG-LL-317 | ALL | 0.2 | 0.96 | 4.68 | 0.0 |
RS4-11 | ALL | 0.9 | 0.99 | 1.00 | 0.1 |
MOLT-4 | ALL | 1.3 | 0.91 | 0.69 | 2.1 |
CCRF-CEM (1) | ALL | 0.7 | 0.99 | 1.25 | 0.0 |
CCRF-CEM (2) | ALL | 0.6 | 0.96 | 1.48 | 0.0 |
Kasumi-1 | AML | 0.8 | 0.99 | 1.05 | 0.4 |
Karpas-299 | ALCL | 0.4 | 0.98 | 1.95 | 0.0 |
Ramos-RA1 | NHL | 0.9 | 0.95 | 0.95 | 0.0 |
Median Summary Data | 0.9 | 0.97 | 1.00 | 0.10 | |
Minimum | 0.2 | 0.88 | 0.18 | 0.00 | |
Maximum | 4.7 | 0.99 | 4.68 | 3.49 |